By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dimension Therapeutics 

840 Memorial Drive, 4th Floor

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-401-0011 Fax: n/a


Dimension Therapeutics is a gene therapy company developing novel treatments for rare diseases

Dimension is focused on advancing its platform of gene therapy programs in rare diseases through clinical development, starting with lead programs in hemophilia, and building out a world-class product engine for adeno-associated virus (AAV) therapeutics across a wide array of single-gene rare diseases.

Key Statistics

Ownership: Public

Web Site: Dimension Therapeutics
Employees: n/a
Symbol: DMTX


Company News
Cambridge's Dimension Therapeutics (DMTX) Tanks to a New Low After Revealing Interim Hemophilia B Data 2/1/2017 5:14:18 AM
Aptuit LLC And Dimension Therapeutics Enter Strategic Partnership To Advance Select Dimension Programs Toward IND Filing 7/7/2016 6:21:14 AM
3 Biotech Stocks Flying High Under-the-Radar 5/26/2016 6:31:07 AM
Dimension Therapeutics Announces Preclinical Data From Bayer-Partnered Hemophilia A Program At American Society For Gene And Cell Therapy (ASGCT) Annual Meeting 5/9/2016 8:07:57 AM
Like Dimension Therapeutics, More Than Half of Yumanity's Employees are Women 2/11/2016 3:12:03 PM
Dimension Therapeutics Reports Recent Corporate Progress and Third Quarter 2015 Financial Results 12/7/2015 8:28:32 AM
Dimension Therapeutics Inks Huge Lease for a New Lab and Office Space in Woburn 11/4/2015 6:31:16 AM
Dimension Therapeutics Prices IPO at Lower End of the Range But Still Manages to Reel in $72 Million 10/22/2015 6:04:24 AM
Dimension Therapeutics Elects Dr. Alan B. Colowick To Its Board Of Directors 9/22/2015 11:31:42 AM
Dimension Therapeutics Announces FDA Fast Track Designation For Lead Candidate DTX101 In Patients With Hemophilia B 9/17/2015 10:42:21 AM